Membraneproperties, expression levels of GFAP and related cascades, branching,and synaptic astrocytic activity should be considered when designingtreatments for AD, as these factors are important for efficient astrocyticglutamate uptake and proper neurotransmission in the brain. Here, GFAP is linked to Alzheimer disease.